Aurinia Pharmaceuticals Inc

Mid-Cap Stocks Biotech Stocks Healthcare Stocks

$16.41

+0.20 (+1.23%)

As of Nov 7, 1:43 AM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 10 77%

Hold 3 23%

Sell 0 0%

Price Target

Analyst Price Target +147.7% upside

Low Target $34.07

Average Target $40.64

High Target $61.77

Current Price $16.41

Current
$16.41

Target
$40.64

$34.07 $40.64 avg $61.77

Scenario Analysis

Bear Case

$34.07

107.6%

Low target

Base Case

$40.64

+147.7%

Avg target

Bull Case

$61.77

+276.4%

High target

Risk/Reward

2.6x

Favorable

Price in Context

52-Week High

$19.25

-14.8% from high

52-Week Low

$13.33

+23.1% from low

Target vs 52W High

$40.64

+111.1% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	39	82%	$257.58	-11.6%
AMGN Amgen Inc	Hold	42	43%	$190.87	-58.5%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+117.3%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	82%	$438.34	-19.9%
MRNA Moderna Inc	Hold	31	35%	$149.45	-41.2%
REGN Regeneron Pharmaceuticals	Buy	37	70%	$76.80	-91.5%
NTRA Natera Inc	Strong Buy	30	90%	$142.91	-54.0%
RVMD Revolution Medicines Inc	Strong Buy	29	93%	$114.11	-40.7%